ADVA sync solution enables major Chilean telco to roll out 5G-ready network
28.10.2019 15:00:00 EET | Business Wire | Press release
ADVA (FSE: ADV) today announced that its Oscilloquartz synchronization technology is enabling one of Chile’s largest communication service providers (CSPs) to roll out LTE Advanced (LTE-A) connectivity across the country and prepare for 5G. The OSA 5430 Series and OSA 5410 Series of PTP grandmaster clocks and GNSS receivers deliver stringent phase synchronization in the core and in the access network, enabling the company to address rapidly rising customer demand for premium services such as high-definition video streaming. The deployment strengthens ADVA’s position in the market with its timing technology now synchronizing more of Chile’s major CSP networks than any other supplier’s solutions. The network is being installed by ADVA’s long-term partner Sistemas de Instrumentación Ltda.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191028005386/en/
The OSA 5430 Series and OSA 5410 Series are enabling one of Chile’s largest CSPs to roll out national LTE-A connectivity (Photo: Business Wire)
“Being selected to transform the sync network of another of Chile’s key CSPs highlights the unique benefits of our grandmaster clocks and GNSS receiver portfolio. With high-quality oscillators guaranteeing unbeatable holdover and the continual assurance of in-service sync with our built-in probes, our technology offers the most complete and comprehensive solution for advanced timing in telecom networks. It will generate value for years to come,” said Gil Biran, general manager, Oscilloquartz. “Our mission is to provide exceptional service to all of our customers. With our technology and ongoing support, we’re empowering another major company to reshape Chile’s telecommunication landscape, reaching more people than ever while continuing to deliver unrivalled quality of service.”
By deploying the small yet versatile OSA 5410 Series in the access networks, the CSP is providing advanced, time-sensitive mobile connectivity throughout Chile, including previously underserved regions. At once a mini-grandmaster, boundary clock, slave device and sync probe, ADVA’s multipurpose devices lead the industry in terms of adaptability and innovation. At its core, the company is utilizing the OSA 5430 Series, which offers full hardware redundancy, significantly reducing downtime. This high-capacity unit also provides unprecedented scale, supporting speeds of up to 10Gbit/s. Additionally, the OSA 5410 and 5430 both support assisted partial timing support (APTS) and feature Oscilloquartz’s best-in-class oven-controlled crystal oscillators, which offer exceptional holdover performance even in the most challenging conditions.
"We work closely with our partner ADVA to deliver world-class technology that ensures unbeatable quality and availability. Their Oscilloquartz grandmasters are the most advanced timing solutions on the market. Ideal for distributing ultra-precise, incredibly reliable phase and time-of-day information, these devices are now providing the heartbeat of another of Chile’s leading CSPs,” commented Danor Quinteros, CEO, Sistemas de Instrumentación Ltda. “One of the crucial elements of this deployment was bringing synchronization close to the end user where it’s most needed. The compact and feature-rich OSA 5410 devices in the access network and the high-capacity OSA 5430 in the core infrastructure will be key to delivering ever-faster speeds and latency-sensitive applications.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we're building a truly connected and sustainable future. For more information on how we can help you, please visit us at: www.adva.com.
About Oscilloquartz
Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to- end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA Optical Networking company, we're creating new opportunities for tomorrow's networks. For more information, please visit us at: www.oscilloquartz.com.
Published by:
ADVA Optical Networking SE, Munich, Germany
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191028005386/en/
Contact information
For ADVA press:
Gareth Spence
t +44 1904 699 358
public-relations@adva.com
For ADVA investors:
Stephan Rettenberger
t +49 89 890 665 854
investor-relations@adva.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
